Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

SCG Cell Therapy Opens State-of-the-art Facility in Singapore

Thursday, July 20, 2023

SCG Cell Therapy has announced the opening of its Cell Therapy cGMP Manufacturing Facility and R&D Centre in Singapore. 

The state-of-the-art facility builds upon SCG's expertise in advanced cell therapy manufacturing and human-induced Pluripotent Stem Cell (iPSC) technology, offering great promise for the region's medical landscape.

This new facility enables to supply cell therapy products to partner hospitals across Asia Pacific, North America, and Europe, enhancing accessibility to cutting-edge treatments worldwide. This development aligns with Singapore's advanced manufacturing initiatives, signifying a major step forward in cell therapy manufacturing within the region.

The opening of the R&D centre also represents a significant step for SCG Cell Therapy. This facility will play a pivotal role in supporting the research of its pipeline of cell therapy product candidates, aligning with the Singaporean government's vision to establish the country as a global innovation hub.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024